1. A novel histone deacetylase 1 and 2 isoform-specific inhibitor alleviates experimental Parkinson's disease. (January 2016) Authors: Choong, Chi-Jing; Sasaki, Tsutomu; Yasuda, Toru; Hayakawa, Hideki; Baba, Kousuke; Hirata, Yoshiyuki; Uesato, Shinichi; Mochizuki, Hideki Journal: Parkinsonism & related disorders Issue: Volume 22(2016)Supplement 2 Page Start: e191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Discovery of new low-molecular-weight p53–Mdmx disruptors and their anti-cancer activities. Issue 8 (15th April 2016) Authors: Uesato, Shinichi; Matsuura, Yoshihiro; Matsue, Saki; Sumiyoshi, Takaaki; Hirata, Yoshiyuki; Takemoto, Suzuho; Kawaratani, Yasuyuki; Yamai, Yusuke; Ishida, Kyoji; Sasaki, Tsutomu; Enari, Masato Journal: Bioorganic & medicinal chemistry Issue: Volume 24:Issue 8(2016) Page Start: 1919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Isozyme-specific histone deacetylase 1/2 inhibitor K560 attenuates oxidative stress-induced retinal cell death. (10th January 2023) Authors: Tawarayama, Hiroshi; Hirata, Yoshiyuki; Uchida, Keiko; Himori, Noriko; Uesato, Shinichi; Nakazawa, Toru Journal: Neuroscience letters Issue: Volume 793(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗